cancer

Featured
Campaigners set out proposals for a better deal for low-income taxpayers
Academy of Medical Sciences

Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage,… Read more »

Latest articles

News
Health watchdog under fire for refusing use of two bowel cancer drugs on the NHS
Charities condemn NHS cancer drug ruling

Cancer charities have today condemned the decision by the health watchdog not to make two bowel cancer drugs available on the NHS. The National Institute for Clinical Excellence (Nice) decided that bevacizumab (Avastin) and cetuximab (Erbitux), which cost £17,000 and £12,000 per patient respectively, were not cost effective given the other demands on the NHS… Read more »

News
Report finds wide variations in NHS spending across the country
PCT spending on key conditions ‘varies widely’

There are wide variations in the amount of money NHS trusts spend on individual diseases and healthcare conditions, a new report warns. An analysis of primary care trust (PCT) spending over the past two years questions how consistently priorities are decided across the NHS, and raises concerns about the impact on patient care. The King’s… Read more »